ANZCTR search results

This study (called TELE-CONNECT) is a telehealth program to deliver pelvic floor muscle training to women with gynaecological cancer who suffer from urinary incontinence. Urinary incontinence affects around one-third of women causing signifcant physical, social, emotional and financial burden. The prevalence of incontinence is doubled in women with gynaecological cancer. Although evidence supports pelvic floor muscle training as first-line treatment for urinary incontinence, it is not known whether this treatment is as effective for women following gynaecological cancer treatment. This will be the first randomised trial to address this vital clinical question using the novel method of telehealth. Who is it for? You may be eligible for this study if you are an adult female following cancer treatment (with and without radiotherapy) for Stage I, II or III uterine, cervical, fallopian tube, primary peritoneal or ovarian cancer or borderline ovarian tumour. Study details: Participants who consent to be contacted by the research team will receive a phone call to determine their eligibility. Those who are suitable for the study and consent to participate will complete a baseline assessment and record any bladder leakage experienced over a 7-day period using an ‘Accident Diary’. They will then be asked to participate in one of two different treatment groups 1) usual care or 2) pelvic floor physiotherapy delivered via video-calls. Each participant is put into a group by chance (randomly) using a computer program. Participants in both groups will be sent high quality bladder and bowel advice handouts. Group 1 will receive one, 15-minute telephone call with a female member of the research team. Group 2 will receive an intensive, supervised, 16-week telehealth-delivered pelvic floor muscle training program (including 8 video-consultations) from a female, qualified and experienced physiotherapist. They will also receive their own pelvic floor muscle biofeedback device. All participants will complete questionnaires at the end of 17 and 52 weeks from the commencement of the study. It is hoped that this research trial will demonstrate that a 16-week, physiotherapist-supervised, telehealth-delivered pelvic floor muscle training program can reduce urinary incontinence compared with usual care, in women following gynaecological cancer treatment.

Comparison of the Slider prong Continuous positive airway pressure (CPAP) interface to the standard Fisher and Paykel CPAP interface in terms of effectiveness for the management of neonatal respiratory distress syndrome, incidence of nasal trauma and acceptability to nursing staff and parents of babies with respiratory distress syndrome in the Mercy Womens Neonatal intensive care unit.

Prior research has found that couples continue after multiple unsuccessful cycles of IVF despite being aware of limited chances of success because they interpret their own chances of success in a positive light (Copp et al., 2020). In addition, many recall hearing anecdotal stories of friends or women at the same clinic having success after a large number of cycles. These anecdotal stories of success seem to play an influential role in fuelling hope and contribute to unrealistic expectations of IVF effectiveness. Whilst consumers scrutinise statistical information, narrative stories cause them to feel compelled (Jaramillo et al., 2019), illustrating the powerful influence of anecdotal stories. This study aims to explore - What is the influence of an anecdotal story of success against the odds despite contrasting statistical information on the low likelihood of success with another cycle of IVF - Does balancing anecdotes of success against anecdotes of failure attenuate their potential effects? Understanding the effect of anecdotal stories on medical decision making will help providers and consumers of IVF services be more aware of the impact anecdotal stories have. This could help patients make better-informed choices and encourage IVF providers to use anecdotes carefully and with caution.

Globally, stroke is a leading cause of death and disability. Despite the impact of stroke on public health, it is considered a lower priority for clinical services and research in many countries. This is possibly due to lack of readily available and accessible data on stroke care and outcomes to inform prevention strategies. Routinely collected coded administrative data are increasingly being used to generate evidence for the prevention and management of stroke. However, accurate clinical coding is critical to ensure these data are valuable and reliable. To ensure and maintain accurate coding, complete and representative clinical documentations are required. Therefore, this project is focused on implementing and evaluating educational interventions for clinicians and coders, in the form of online education on stroke and coding for stroke, to improve documentations and coding for stroke.

ACTMed is a new service designed to proactively find and address medicine problems before they cause harm. Participating pharmacists will use a specially designed software program (ACTionable Medication safety dashboard) that works within health IT systems to detect medicines problems. ACTMed works by bringing pharmacists, consumers and general practitioners together to deal with medicine problems. After the initial co-design/pilot phase, we will run a staged trial across at least 38 health services (Aboriginal Community Controlled Health Organizations (ACCHOs) and general practitioner practices) in Queensland and Victoria to assess how effective it is and whether it is good value for money.

Speech sound disorders are one of the most common types of communication disorder in young children. Children with speech sound disorders often have consistent error patterns such as substituting one sound (e.g. ‘k’) for a different sound (e.g. ‘t’). One common error pattern is deleting the weak or unstressed syllable in a word (e.g. saying ‘mato’ instead of ‘tomato’). Children who persist with these types of errors in their speech have an increased risk of literacy difficulties during the school years, so it is important that these speech errors are addressed. Currently, there are no evidence-based interventions for speech sound errors where children delete syllables in words. In this small scale research study, we want to find out if a commonly used speech pathology therapy known as, ‘minimal pairs therapy’, can help children to say long words more easily. Currently, minimal pairs therapy involves asking children to listen to and say words that only differ by one sound (i.e., hear and say pairs of words with minimal differences between them, such as ‘tea’ and ‘key’). This therapy approach has been used for short words and to correct specific consonants in error, since 1981. For example, if a child never uses ‘k’ in words and substitutes all ‘k’’ sounds with ‘t’ sounds, a speech pathologist might show a child a picture of a ‘key’ and a cup of ‘tea’. The speech pathologist would ask the child to practice naming the pictures using child friendly games and activities, and help them by modelling the words or giving specific prompts describing how to say the target sound in the word. While there is evidence suggesting minimal pairs therapy technique works for short words, it is yet to be tested with long words. We have proposed four research questions: In children with phonological impairment (a common type of speech sound disorder), does minimal pairs therapy targeting weak syllable deletion result in a reduction in weak syllable deletion in: 1. trained words with word-initial weak syllables? 2. untrained words with word-initial weak syllables? 3. untrained words with word-internal weak syllables? 4. a five-minute story retell task?

The objective of the study is to evaluate performance of nasal and throat samples tested using the trial device EuGeni SARS-CoV-2 Ag RDT against standard of care PCR.

The purpose of this study is to investigate the effect of a combined exercise and education intervention on biomechanics in those with knee osteoarthritis. We currently do not understand the reasons why people may improve with exercise interventions. This exploratory study will examine changes in muscle activation patterns and joint load following the GLA:D® program and see if this is related to improvements in pain or function or influences a person’s willingness to undertake surgery. GLA:D® (Good Living Arthritis Denmark) is a program for hip and knee osteoarthritis consisting of 2 education sessions and 12 physiotherapy delivered group exercise classes delivered twice weekly over 6-8 weeks. Biomechanical measurements such as knee joint loads (knee adduction moment and knee flexion moment) and muscle activation patterns (timings and co-contractions) will be measured at baseline and immediately following the GLA:D® program at 8 weeks. The relationship between biomechanical changes following the program and changes in pain and function or a person's willingness to undertake joint replacement surgery will be evaluated.

Chronic Obstructive Pulmonary Disease (COPD) is a common chronic condition that can progress to disability and death. COPD frequently occurs in the context of other long-term conditions (multimorbidity). There is a lack of effective self-management programs for COPD in primary care. This cluster randomised controlled trial will test a self-management support intervention, based on the Health Belief Model (HBM), delivered primarily by Practice Nurses (PN) that is tailored to patient needs and recognises the context of multimorbidity. In a pilot study, this innovative intervention was associated with improvements in patient activation, COPD-related quality of life and COPD knowledge. The APCOM trial will rigorously test, using a cluster randomised controlled design, whether this intervention is effective in improving quality of life, decreasing COPD exacerbations and increasing patient knowledge of COPD and can be effectively implemented in primary care.

The use of antidepressants (ADs) is increasing globally, including within Australia, which has one of the highest rates of AD prescribing. Despite clear benefits for many people, there is reason to believe that the ongoing use of these medications is often not properly monitored or stopped (deprescribed) when a person returns to better mental health. This trial sets out to test how well an online support tool (WiserAD) can help patients and their general practitioner to manage the careful and appropriate reducing and stopping of antidepressants, in primary care patients. It is anticipated that WiserAD (a novel, structured approach to deprescribing ADs) is more effective than usual practice in enabling GPs to help primary care patients to cease (or decrease) their AD medication whilst maintaining their mental health and wellbeing.